Terumo (OTCMKTS:TRUMY) Stock Passes Below 50-Day Moving Average – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $14.75 and traded as low as $13.50. Terumo shares last traded at $13.67, with a volume of 228,682 shares changing hands.

Terumo Stock Performance

The company has a debt-to-equity ratio of 0.07, a current ratio of 2.51 and a quick ratio of 1.46. The company has a market cap of $20.24 billion, a price-to-earnings ratio of 22.78 and a beta of 0.75. The firm has a 50 day simple moving average of $14.75 and a 200-day simple moving average of $16.25.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.75 billion. Terumo had a return on equity of 9.39% and a net margin of 12.35%.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.